Breast Cancer clinical trials
Showing 551–600 of 1,067 active trials. Describe your situation to see which ones you may be eligible for.
- Adherence Intervention in Patients With Metastatic Breast Cancer
- A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)
- Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
- Asciminib in HER2+ Breast Cancer Brain Metastases
- A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
- Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD
- Evaluation and Outcomes of SAVI Scout MD for Localized Breast Surgery
- Screening For BCRL In Targeted Therapy For Breast Cancer
- Pilot SMART of a Remotely Delivered, Adaptive Physical Activity Intervention for Breast Cancer Survivors
- mHealth to Improve Medication Adherence Among Latina Breast Cancer Patients Experiencing Non-Medical Drivers of Health
- A Navigation Program to Improve Survivorship Support Service Participation Among Non-metastatic Breast Cancer Survivors
- Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy
- DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients
- A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- WE-CARE Community Health Forums to Increase Breast Cancer Screening and Clinical Trial Participation for Rural and Low Income Women
- Decision Support Tool for Patients With Advanced Breast Cancer
- HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
- Magnetic Resonance Imaging in Radiotherapy for Breast Cancer
- Oncoplastic Surgery Outcomes Database
- Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns
- Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction
- EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
- ctDNA Positive Patients Diagnosed With cT1bN0 and cT1cN0 TNBC
- The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients
- Factors Associated With Breast Cancer Risks and Outcomes
- Active Surveillance in Older Women With ER+ Breast Cancer
- Living Well With Advanced Breast Cancer
- Breast Mapping and Detection of Suspicious Breast Lesions Using Feminai
- Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening
- Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
- UCF MammoChat: Image Repository
- Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
- Everyday Exposures: How Chemicals and Weight Impact Breast Cancer Risk
- Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer
- B.Brilliant Revelation Comparision Study
- Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs
- Surviving Daily Life
- Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning
- Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
- Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy
- Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer
- VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
- A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients
- A Novel Approach Utilizing Organ Specific Age Proteomics
- Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer
- Postoperative Outcomes and Patient Satisfaction With Mayo Clinic Florida Care Hotel After Mastectomy and Tissue Expander Placement
- A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
- Rutgers University Study of the Genetics of Breast Cancer.
- Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients
- Study in Patients With Breast Cancer Leptomeningeal Metastasis
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.